Changes in antimicrobial resistance and outcomes of health care-associated infections.
Anti-Bacterial Agents
/ pharmacology
Antifungal Agents
/ pharmacology
Bacteremia
/ microbiology
Bacteria
/ drug effects
Bacterial Infections
/ drug therapy
Candida
/ drug effects
Cross Infection
/ drug therapy
Drug Resistance, Bacterial
Fungemia
/ microbiology
Humans
Mycoses
/ drug therapy
Retrospective Studies
Blood stream infections
Colistin resistance
Health care
associated infections
Journal
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology
ISSN: 1435-4373
Titre abrégé: Eur J Clin Microbiol Infect Dis
Pays: Germany
ID NLM: 8804297
Informations de publication
Date de publication:
Aug 2021
Aug 2021
Historique:
received:
25
09
2020
accepted:
20
12
2020
pubmed:
16
2
2021
medline:
31
8
2021
entrez:
15
2
2021
Statut:
ppublish
Résumé
To describe the change in the epidemiology of health care-associated infections (HAI), resistance and predictors of fatality we conducted a nationwide study in 24 hospitals between 2015 and 2018. The 30-day fatality rate was 22% in 2015 and increased to 25% in 2018. In BSI, a significant increasing trend was observed for Candida and Enterococcus. The highest rate of 30-day fatality was detected among the patients with pneumonia (32%). In pneumonia, Pseudomonas infections increased in 2018. Colistin resistance increased and significantly associated with 30-day fatality in Pseudomonas infections. Among S. aureus methicillin, resistance increased from 31 to 41%.
Identifiants
pubmed: 33586014
doi: 10.1007/s10096-020-04140-y
pii: 10.1007/s10096-020-04140-y
doi:
Substances chimiques
Anti-Bacterial Agents
0
Antifungal Agents
0
Types de publication
Journal Article
Multicenter Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
1737-1742Informations de copyright
© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH, DE part of Springer Nature.
Références
Aydin M, Ergonul O, Azap A et al (2018) Rapid emergence of colistin resistance and its impact on fatality among healthcare-associated infections. J Hosp Infect 98:260–263
doi: 10.1016/j.jhin.2017.11.014
Isler B, Keske S, Aksoy M et al (2019) Antibiotic overconsumption and resistance in Turkey. Clin Microbiol Infect 25:651–653
doi: 10.1016/j.cmi.2019.02.024
Mitchell R, Taylor G, Rudnick W et al (2019) Trends in health care-associated infections in acute care hospitals in Canada: an analysis of repeated point-prevalence surveys. CMAJ 191:E981–E9E8
doi: 10.1503/cmaj.190361
Ergonul O, Aydin M, Azap A et al (2016) Healthcare-associated Gram-negative bloodstream infections: antibiotic resistance and predictors of mortality. J Hosp Infect 94:381–385
doi: 10.1016/j.jhin.2016.08.012
CDC/NHSN Surveillance Definitions for Specific Types of Infections. Center for Disease Control and Prevention (CDC) 2017
CLSI (2016) Subcommittee on Antimicrobial Susceptibility Testing. Clinical and Laboratory Standards Institute
Dogan O, Yesilkaya A, Menekse S et al (2020) Effect of initial antifungal therapy on mortality among patients with bloodstream infections with different Candida species and resistance to antifungal agents: a multicentre observational study by the Turkish Fungal Infections Study Group. Int J Antimicrob Agents 56(1):105992. https://doi.org/10.1016/j.ijantimicag.2020.105992
doi: 10.1016/j.ijantimicag.2020.105992
pubmed: 32335275
Bassetti M, Giacobbe DR, Vena A et al (2019) Incidence and outcome of invasive candidiasis in intensive care units (ICUs) in Europe: results of the EUCANDICU project. Crit Care 23:219
doi: 10.1186/s13054-019-2497-3
Jean SS, Chang YC, Lin WC, Lee WS, Hsueh PR, Hsu CW (2020) Epidemiology, treatment, and prevention of nosocomial bacterial pneumonia. J Clin Med 9
Ewig S, Kolditz M, Pletz MW, Chalmers J (2019) Healthcare-associated pneumonia: is there any reason to continue to utilize this label in 2019? Clin Microbiol Infect 25:1173–1179
doi: 10.1016/j.cmi.2019.02.022
Bakthavatchalam YD, Veeraraghavan B (2017) Challenges, issues and warnings from CLSI and EUCAST Working Group on polymyxin susceptibility testing. J Clin Diagn Res 11:DL03–DDL4
pubmed: 28969129
pmcid: 5620769
Girardello R, Cury AP, Franco MRG et al (2018) Colistin susceptibility testing and Vitek-2: is it really useless? Diagn Microbiol Infect Dis 91:309–311
doi: 10.1016/j.diagmicrobio.2018.03.019
EARS (2019) Surveillance of antimicrobial resistance in Europe 2018. In: Stockholm: European Centre for Disease Prevention and Control (ECDC)
Balkhy HH, El-Saed A, Alshamrani MM et al (2020) Ten-year resistance trends in pathogens causing healthcare-associated infections; reflection of infection control interventions at a multi-hospital healthcare system in Saudi Arabia, 2007-2016. Antimicrob Resist Infect Control 9:21
doi: 10.1186/s13756-020-0678-0